Bridgewater L C, Manning F C, Woo E S, Patierno S R
Department of Pharmacology, George Washington University Medical Center, Washington, District of Columbia 20037.
Mol Carcinog. 1994 Mar;9(3):122-33. doi: 10.1002/mc.2940090304.
Carcinogenic chromium (Cr6+) enters cells via the sulfate transport system and undergoes intracellular reduction to trivalent chromium, which strongly adducts to DNA. In this study, the effect of adducted trivalent chromium on in vitro DNA synthesis was analyzed with a polymerase-arrest assay in which prematurely terminated replication products were separated on a DNA sequencing gel. A synthetic DNA replication template was treated with increasing concentrations of chromium(III) chloride. The two lowest chromium doses used resulted in biologically relevant adduct levels (6 and 21 adducts per 1,000 DNA nucleotides) comparable with those measured in nuclear matrix DNA from cells treated with a 50% cytotoxic dose of sodium chromate in vivo. In vitro replication of the chromium-treated template DNA using the Sequenase version 2.0 T7 DNA polymerase (United States Biochemical Corp., Cleveland, OH) resulted in dose-dependent polymerase arrest beginning at the lowest adduct levels analyzed. The pattern of polymerase arrest remained consistent as chromium adduct levels increased, with the most intense arrest sites occurring 1 base upstream of guanine residues on the template strand. Replication by the DNA polymerase I large (Klenow) fragment as well as by unmodified T7 DNA polymerase also resulted in similar chromium-induced polymerase arrest. Interstrand cross-linking between complementary strands was detected in template DNA containing 62, 111, and 223 chromium adducts per 1,000 DNA nucleotides but not in template containing 6 or 21 adducts per 1,000 DNA nucleotides, in which arrest nevertheless did occur. Low-level, dose-dependent interstrand cross-linking between primer and template DNA, however, was detectable even at the lowest chromium dose analyzed. Since only 9% of chromium adducts resulted in polymerase arrest in this system, we hypothesized that arrest occurred when the enzyme encountered chromium-mediated interstrand DNA-DNA cross-links between either the template and a separate DNA molecule or the template and its complementary strand in the same molecule. These results suggest that the obstruction of DNA replication by chromium-mediated DNA-DNA cross-links is a potential mechanism of chromium-induced genotoxicity in vivo.
致癌性铬(Cr6+)通过硫酸盐转运系统进入细胞,并在细胞内还原为三价铬,三价铬会与DNA强烈结合。在本研究中,采用聚合酶阻滞试验分析了结合态三价铬对体外DNA合成的影响,该试验中,提前终止的复制产物在DNA测序凝胶上进行分离。用浓度递增的氯化铬处理合成的DNA复制模板。所使用的两个最低铬剂量导致了与体内用50%细胞毒性剂量的铬酸钠处理的细胞的核基质DNA中测得的加合物水平相当的生物学相关加合物水平(每1000个DNA核苷酸中有6个和21个加合物)。使用Sequenase 2.0版T7 DNA聚合酶(美国生物化学公司,俄亥俄州克利夫兰)对经铬处理的模板DNA进行体外复制,从所分析的最低加合物水平开始就出现了剂量依赖性的聚合酶阻滞。随着铬加合物水平的增加,聚合酶阻滞模式保持一致,最强烈的阻滞位点出现在模板链上鸟嘌呤残基上游1个碱基处。DNA聚合酶I大片段(Klenow片段)以及未修饰的T7 DNA聚合酶进行的复制也导致了类似的铬诱导的聚合酶阻滞。在每1000个DNA核苷酸含有62、111和223个铬加合物的模板DNA中检测到互补链之间的链间交联,但在每10,000个DNA核苷酸含有6个或21个加合物的模板中未检测到,不过在该模板中仍发生了阻滞。然而,即使在分析的最低铬剂量下,也能检测到引物与模板DNA之间低水平的、剂量依赖性的链间交联。由于在该系统中只有9%的铬加合物导致聚合酶阻滞,我们推测当酶遇到模板与另一个DNA分子之间或同一分子中模板与其互补链之间由铬介导的DNA - DNA链间交联时,就会发生阻滞。这些结果表明,铬介导的DNA - DNA交联对DNA复制的阻碍是铬在体内诱导遗传毒性的一种潜在机制。